Recuro Health

Recuro Health is an integrated digital health solutions company that operates a virtual-first care delivery platform, described on its site as a "Digital Medical Home." Its core virtual care offerings are primary care, behavioral health and urgent care, complemented by supplemental benefits including pharmacy/prescription benefit, care management, health advocacy and a physician locator. Additional listed products include on-demand counseling, pediatric behavioral health, a wellness program, virtual musculoskeletal therapy and a bundled "Recuro Complete Care" offering. The platform incorporates health risk assessments, at-home lab testing and genomic/genetic screening, which the company positions as inputs for risk stratification and preventive care.

Services are delivered nationwide in the United States, 24 hours a day, year-round, through a mobile app (Recuro Care) and an online member portal, with behavioral health consultations available across 50 states by scheduled appointment. Recuro says it uses its own proprietary platform for EMR, scheduling, visits and e-prescribing, with prescriptions transmitted electronically via SureScripts or by phone to the member's chosen pharmacy; the company does not dispense drugs and its providers do not prescribe DEA-controlled or non-therapeutic substances. Providers must be board-certified in family medicine, emergency medicine, internal medicine, pediatrics or psychiatry, have at least two years of clinical experience and active state and DEA licenses, and are screened against NCQA/NPDB verification standards.

The company was launched in March 2021 and, according to a 2021 press release, was led by members of the founding Teladoc team. Michael Brombach is Chief Executive Officer and co-founder; other named executives include Jon O'Toole (Chief Revenue Officer), Kate Sowerwine, MD (CMO and President, P.A.), Jennifer Balliet (SVP and Chief People Officer) and Matthew Turrin (Chief Accounting Officer). William D. Paiva, Ph.D. was identified in 2021 as chairman of the board.

Founding story

Recuro Health launched in March 2021 and raised an oversubscribed seed round that month. ARCH Venture Partners described the company as led by the founding Teladoc team that helped create the digital health category over twenty years earlier. Michael Brombach co-founded the company and serves as CEO; he previously founded SupDoc, an AI-powered healthcare platform that was acquired by Recuro Health, and before that was an executive in Accenture Strategy's healthcare practice.

Business model

Recuro sells an enterprise-ready SaaS virtual care platform and associated clinical services to employers, health plans, third-party administrators and providers, who make the services available to their members or employees. Buyers can configure a bundle from a catalog of core virtual care services and supplemental benefits, with white-labeling and customization supported. Members receiving Recuro through a group benefit may pay nothing at the point of care; consumer sign-ups are also possible and Recuro accepts major credit and debit cards.

Sources indicate services are typically purchased by employers, health plans and benefit administrators as a benefit offering, with member cost depending on the plan; direct consumer payment by card is also accepted. Specific pricing or contract structures are not disclosed in the sources.

Traction

The website states more than 100,000 telemedicine consults per month across all US states, a satisfaction rate above 95% (elsewhere cited as 92% member satisfaction), and that members report their medical issue was resolved without further care more than 95% of the time. Marketing materials claim clients saved an average of approximately $265 per virtual urgent care visit and 3.5x–6x ROI over the prior 12 months. Recuro's COVID-19 testing solution was selected as one of a dozen companies from hundreds to collaborate with HHS, NIH and the FDA during the pandemic, and was featured at the ACCE Innovation Summit sponsored by RADx.

Latest developments

Recuro promotes HITRUST certification, recognition by Newsweek and inclusion among the top 25 digital health companies by Becker's and Healthcare Technology Report, and publishes a Trends Report on integration and cost containment claiming 3.5x–6x ROI. Recent blog content and scheduled 2026 conference appearances (including HVBA in San Antonio) indicate ongoing commercial activity.